Rep. Kevin Hern (R-OK) Sells IQVIA (IQV) Stock

Oklahoma Congressman Kevin Hern sold shares of IQVIA Holdings Inc. (NYSE: IQV) on September 14, 2026, in a transaction valued between $15,001 and $50,000. The sale was reported on September 25, 2026, and Hern is a member of the Republican Party representing Oklahoma's 1st Congressional District.

Inside Kevin Hern's Trade

Hern's transaction involved selling shares of IQVIA, a key player in the healthcare sector that provides clinical research services. The shares were sold at a price of $270.45 on the day of the sale. This transaction adds to recent activity where Hern sold shares of other companies, including Rockwell Automation and NextEra Energy.

Other Institutional Activity in IQVIA

Several institutional investors have also adjusted their positions in IQVIA recently. Blackrock Inc. lowered its stake by 477,877 shares, bringing its total to 14,549,693 shares valued at approximately $3.85 billion. Vanguard Capital Management LLC reduced its holdings by 122,405 shares, ending with 10,905,053 shares worth about $2.88 billion. State Street Corporation added a modest 31,403 shares, increasing its total to 7,508,244 shares valued at around $1.98 billion.

IQVIA Holdings Inc. Stock Up 1.5%

IQVIA shares are currently trading at $270.45, which is close to the recent high of $273.88. The stock has shown strong performance, with a current P/E ratio of about 33.5. This places it within a competitive range in the diagnostics and research industry, especially as it operates well above its 200-day moving average.

Recent Earnings

In its most recent earnings report, IQVIA reported revenue of approximately $16.98 billion, representing a growth rate of 8.7%. The company also achieved an EPS of $8.05. The next earnings report is expected on November 3, 2026.

Insider Buying and Selling at IQVIA Holdings Inc.

Recent insider transactions have shown significant activity. Officer Berkshire James Grant sold 2,668 shares on September 2, 2026, valued at about $697,228. Additionally, Officer Staub Walter. Richard III sold 5,500 shares on August 3, 2026, for roughly $1.28 million. CEO Ari Bousbib also sold a substantial 106,279 shares on July 29, 2026, valued at about $26.09 million.

Analysts Set New Price Targets

Analysts have been actively updating their ratings for IQVIA. On September 29, 2026, RBC Capital maintained an 'Outperform' rating with a new price target of $319. On October 7, 2026, both Mizuho and Barclays also maintained their positive outlook with targets of $300. The consensus among 18 analysts is a strong buy, with an average price target of about $277.94.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a leading provider of clinical research services and healthcare intelligence. It serves the life sciences industry across various regions, including the Americas and Europe. The company has a substantial workforce of around 94,000 employees and operates through segments focused on technology, research, and medical solutions.

Bottom Line

Investors should note that the reported sale reflects past activity and may not indicate Hern's current position in IQVIA. With the next earnings date approaching on November 3, 2026, and analysts actively updating their ratings, developments in the company will be closely monitored.